Higher-order aberration measurements: Comparison between Scheimpflug and dual Scheimpflug-Placido technology in normal eyes.


Journal

Journal of cataract and refractive surgery
ISSN: 1873-4502
Titre abrégé: J Cataract Refract Surg
Pays: United States
ID NLM: 8604171

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 08 2018
revised: 25 10 2018
accepted: 19 11 2018
pubmed: 5 2 2019
medline: 15 8 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

To compare higher order aberrations (HOAs) in normal eyes between a Scheimpflug imaging system (Pentacam HR) and dual Scheimpflug-Placido imaging system (Galilei G4). Emory University, Atlanta, Georgia, and the University of Southern California, Los Angeles, USA. Retrospective case series. Eyes screened for refractive surgery were evaluated sequentially using a Scheimpflug device and a dual Scheimpflug-Placido device. Differences, correlations, and agreement between values for total root mean square (RMS), trefoil, coma, and spherical aberration were analyzed, and Bland-Altman plots were generated. One hundred five eyes of 105 patients (44 men, 61 women) were evaluated. Total RMS, coma, and trefoil were significantly different between groups (all P < .001), while spherical aberration values were not. There was moderate correlation between devices for trefoil (r = 0.475 to 0.652), coma (r = 0.574 to 0.651), and spherical aberration (r = 0.483) and a strong correlation for total cornea RMS (r = 0.817). There was no directional bias between groups. The 95% limits of agreement for absolute values was 0.039 μm for trefoil at 30 degrees, 0.405 μm for trefoil at 0 degree, 0.553 μm for horizontal coma, 0.545 μm for vertical coma, 0.318 μm for spherical aberration, and 0.617 μm for RMS. A Scheimpflug imaging device and dual Scheimpflug-Placido imaging device generated statistically different values for total cornea HOAs; however, the correlation between devices was moderate to strong and there was reasonable agreement in all measures for normal eyes. Based on these findings, the devices appear functionally equivalent for clinical use, although caution is warranted for outcomes-based research protocols that report HOAs.

Identifiants

pubmed: 30713018
pii: S0886-3350(18)30950-7
doi: 10.1016/j.jcrs.2018.11.015
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

490-494

Informations de copyright

Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Auteurs

Andre L Piccinini (AL)

Keck School of Medicine, University of Southern California, Los Angeles, USA; Sadalla Amin Ghanem Eye Hospital, Joinville, SC, Brazil.

Oren Golan (O)

Keck School of Medicine, University of Southern California, Los Angeles, USA; Department of Ophthalmology, Tel Aviv Souraski Medical Center, Tel Aviv, Israel; Tel Aviv University, Tel Aviv, Israel.

Farhad Hafezi (F)

Keck School of Medicine, University of Southern California, Los Angeles, USA; USC Roski Eye Institute, Los Angeles, USA; ELZA Institute, Dietikon/Zurich, Switzerland; Ocular Cell Biology Group, University of Zurich, Zurich, Switzerland; University of Wenzhou, Wenzhou, China.

J Bradley Randleman (JB)

Keck School of Medicine, University of Southern California, Los Angeles, USA; USC Roski Eye Institute, Los Angeles, USA. Electronic address: randlema@usc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH